×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/25
04:30 pm
nrix
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Low
Report
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
3/19
05:41 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) was upgraded by analysts at Leerink Partnrs to a "hold" rating.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) was upgraded by analysts at Leerink Partnrs to a "hold" rating.
3/17
08:11 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $16.00 price target on the stock.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $16.00 price target on the stock.
3/17
07:07 am
nrix
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia [Yahoo! Finance]
Medium
Report
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia [Yahoo! Finance]
3/17
07:00 am
nrix
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
Medium
Report
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
3/14
04:00 pm
nrix
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/13
04:00 pm
nrix
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
Medium
Report
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
3/4
08:05 am
nrix
Nurix Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Nurix Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
10/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
IN-LINE
Report
6.5%
nurix therapeutics, inc. - common stock
7/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
8.1%
nurix therapeutics, inc. - common stock
4/10/2024
07:00 am
nrix
nurix therapeutics, inc. - common stock
BEAT
Report
-12.5%
nurix therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/28
02:07 pm
nrix
Form DEFA14A Nurix Therapeutics, Inc.
Low
Report
Form DEFA14A Nurix Therapeutics, Inc.
3/28
09:03 am
nrix
Form ARS Nurix Therapeutics, Inc. For: Nov 30
Medium
Report
Form ARS Nurix Therapeutics, Inc. For: Nov 30
3/28
06:03 am
nrix
Form DEF 14A Nurix Therapeutics, Inc. For: May 19
Medium
Report
Form DEF 14A Nurix Therapeutics, Inc. For: May 19
3/13
04:09 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Mar 11 Filed by: Baynes Roy D.
Medium
Report
Form 4 Nurix Therapeutics, Inc. For: Mar 11 Filed by: Baynes Roy D.
3/13
04:07 pm
nrix
Form 3 Nurix Therapeutics, Inc. For: Mar 11 Filed by: Baynes Roy D.
Medium
Report
Form 3 Nurix Therapeutics, Inc. For: Mar 11 Filed by: Baynes Roy D.
3/13
04:03 pm
nrix
Form 8-K Nurix Therapeutics, Inc. For: Mar 11
Medium
Report
Form 8-K Nurix Therapeutics, Inc. For: Mar 11
3/3
05:29 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Mar 03 Filed by: van Houte Hans
Low
Report
Form 4 Nurix Therapeutics, Inc. For: Mar 03 Filed by: van Houte Hans
3/3
04:18 pm
nrix
Form 144 Nurix Therapeutics, Inc. Filed by: van Houte Hans
Low
Report
Form 144 Nurix Therapeutics, Inc. Filed by: van Houte Hans
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: